NuVision Biotherapies, an optics tissue-therapy company, has appointed Tim Precious as its new chief executive officer.
RetinAI is developing artificial intelligence technologies in order to “enable the right decisions sooner in healthcare,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results